RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Bristol-Myers Squibb Debt 2024

Bristol-Myers Squibb Debt

28,308 USD

Bristol-Myers Squibb Dividend yield

Ticker

BMY

ISIN

US1101221083

WKN

850501

In 2024, Bristol-Myers Squibb's total debt was 28,308 USD, a -6.26% change from the 30,197 USD total debt recorded in the previous year.

Bristol-Myers Squibb Aktienanalyse

What does Bristol-Myers Squibb do?

Bristol-Myers Squibb Co is a global biopharmaceutical company focused on the research, development, and production of prescription drugs and biosimilars for the treatment of serious diseases. The company is headquartered in New York, USA, and employs approximately 30,000 people worldwide. Bristol-Myers Squibb ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Bristol-Myers Squibb's Debt Structure

Bristol-Myers Squibb's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Bristol-Myers Squibb's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Bristol-Myers Squibb’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Bristol-Myers Squibb’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Bristol-Myers Squibb Stock

What is the debt of Bristol-Myers Squibb this year?

Bristol-Myers Squibb has a debt level of 28,308 USD this year.

What was the debt of Bristol-Myers Squibb compared to the previous year?

The debt of Bristol-Myers Squibb has increased by -6.26% compared to the previous year dropped.

What are the consequences of high debt for investors in Bristol-Myers Squibb?

High debt can pose a risk for investors of Bristol-Myers Squibb, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Bristol-Myers Squibb?

Low debt means that Bristol-Myers Squibb has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Bristol-Myers Squibb affect the company?

An increase in debt of Bristol-Myers Squibb can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Bristol-Myers Squibb affect the company?

A reduction in debt of Bristol-Myers Squibb can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Bristol-Myers Squibb?

Some factors that can influence the debt of Bristol-Myers Squibb include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Bristol-Myers Squibb so important for investors?

The debts of Bristol-Myers Squibb are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Bristol-Myers Squibb take to change the debt?

To change the debt, Bristol-Myers Squibb can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Bristol-Myers Squibb pay?

Over the past 12 months, Bristol-Myers Squibb paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bristol-Myers Squibb is expected to pay a dividend of 2.43 USD.

What is the dividend yield of Bristol-Myers Squibb?

The current dividend yield of Bristol-Myers Squibb is .

When does Bristol-Myers Squibb pay dividends?

Bristol-Myers Squibb pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Bristol-Myers Squibb?

Bristol-Myers Squibb paid dividends every year for the past 26 years.

What is the dividend of Bristol-Myers Squibb?

For the upcoming 12 months, dividends amounting to 2.43 USD are expected. This corresponds to a dividend yield of 5.42 %.

In which sector is Bristol-Myers Squibb located?

Bristol-Myers Squibb is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bristol-Myers Squibb kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bristol-Myers Squibb from 5/1/2024 amounting to 0.6 USD, you needed to have the stock in your portfolio before the ex-date on 4/4/2024.

When did Bristol-Myers Squibb pay the last dividend?

The last dividend was paid out on 5/1/2024.

What was the dividend of Bristol-Myers Squibb in the year 2023?

In the year 2023, Bristol-Myers Squibb distributed 2.16 USD as dividends.

In which currency does Bristol-Myers Squibb pay out the dividend?

The dividends of Bristol-Myers Squibb are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bristol-Myers Squibb stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Bristol-Myers Squibb

Our stock analysis for Bristol-Myers Squibb Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bristol-Myers Squibb Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.